Efficacy and Safety of NBI-98854 in Subjects With Tardive Dyskinesia

NCT01267188 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
10
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Neurocrine Biosciences